Index of /pdfs/pi

 Name                    Last modified       Size  Description

 Parent Directory        16-Jun-2004 11:50      -  
 1900013.07.pdf          27-Mar-2003 08:55   105k  
 1900018.08.pdf          27-Mar-2003 08:55   322k  
 1900021.05.pdf          27-Mar-2003 08:55   114k  
 1900025.08.pdf          27-Mar-2003 08:55   271k  
 1900028.08.pdf          27-Mar-2003 08:55   104k  
 1900032.05.pdf          27-Mar-2003 08:55   252k  
 1900066.03.pdf          27-Mar-2003 08:55   522k  
 1900102.02.pdf          27-Mar-2003 08:55   104k  
 1900523.07.pdf          27-Mar-2003 08:55   264k  
 1900528.05.pdf          27-Mar-2003 08:56   271k  
 1900531.07.pdf          27-Mar-2003 08:56   169k  
 1900656.03.pdf          27-Mar-2003 08:56   263k  
 1900657.02.pdf          27-Mar-2003 08:56   337k  
 1900689.01.pdf          27-Mar-2003 08:56   105k

Apache/1.3.29 Server at www.unispheremag.com Port 80

Site map PharmaNetics, manufacturer of a platform for point of care monitoring of whole blood coagulation.

This press release contains forward-looking statements regarding future events and the future performance of PharmaNetics that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include risks related to market acceptance, clinical trials and dependence on third party distributors and collaborative partners, including, in particular with regard to the legal proceedings commenced against its development partner, Aventis Pharmaceuticals, which action includes without limitation the following specific risks: material monetary costs associated with the litigation, even if successful; uncertainty of obtaining a favorable outcome; the potentially significant harm to PharmaNetics’ business and financial condition and prospects if it is not successful in timely prosecuting the litigation; jeopardizing strategic relationships with other existing or potential collaborative partners; harmful delays in meeting sales objectives, even if the litigation is successful; and disruption of management time and resources to pursue the litigation. Information concerning these and other of the factors that could cause results to differ materially from those in the forward-looking statements is contained in the Company’s filings with the Securities and Exchange Commission, including Form 10-K, Form 10-Q and Form 8-K reports.